Nichole Orofino
Psychiatric/Mental Health · Auburn, NYNPI 1396449286
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 337 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,528, 6.7 times the $375 reported in 2023. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$828
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$547
- Johnson & Johnson$455
- Neurocrine Biosciences, Inc.$448
- Alkermes, Inc.$401
- plus $1K from 11 others
What the payments were for
- Food & beverage$4,899100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 64 | $1,029 |
| Teva Pharmaceuticals USA, Inc. | 75 | $828 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $547 |
| Johnson & Johnson | 17 | $455 |
| Neurocrine Biosciences, Inc. | 54 | $448 |
| Alkermes, Inc. | 24 | $401 |
| E.r. Squibb & Sons, L.L.C. | 22 | $220 |
| Vanda Pharmaceuticals Inc. | 9 | $214 |
| Otsuka America Pharmaceutical, Inc. | 14 | $213 |
| Axsome Therapeutics, Inc. | 4 | $186 |
| Indivior Inc. | 12 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Gilead | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Corium, LLC | 2 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,899 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 17 | $22,393 |
| RexultiBrexpiprazole | 13 | $18,159 |
| AbilifyAripiprazole | 12 | $9,484 |
| Quetiapine Fumarate | 39 | $1,759 |
| Divalproex Sodium | 32 | $1,747 |
| Sertraline Hcl | 60 | $767 |
| Buspirone Hcl | 40 | $726 |
| Aripiprazole | 16 | $618 |
| Duloxetine Hcl | 43 | $610 |
| Mirtazapine | 38 | $511 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 35 | $494 |
| Olanzapine | 17 | $487 |
| Bupropion XlBupropion Hcl | 29 | $432 |
| Trazodone Hcl | 56 | $375 |
| Risperidone | 13 | $322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,029 | $22,39317 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $213 | $18,15913 claims |
| E.r. Squibb & Sons, L.L.C.Abilify | $220 | $9,48412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Auburn
- Andrew CataloneAuburn$26K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.